Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-5-17
|
pubmed:abstractText |
Porcine peripheral blood mononuclear cells (PBMC) are induced to produce interferon alpha (IFN alpha) following in vitro exposure to coronavirus TGEV (transmissible gastroenteritis virus)-infected glutaraldehyde-fixed cell monolayers or to TGEV virions. In the present report, we examined the possibility that glycosylation of viral proteins could play a major role in interactions with PBMC leading to the production of IFN alpha. Con A pretreatment of TGEV-infected cell monolayers before fixation with glutaraldehyde and exposure to PBMC caused a dose-dependent inhibition of IFN alpha induction, implying that masking of carbohydrates at the surface of infected cells lowered IFN-alpha-induction. Similarly, inhibition of N-linked glycosylation by tunicamycin during viral infection of cell monolayers altered their ability to induce IFN alpha. In addition, complete cleavage of 'complex type' oligosaccharides by peptide-N-glycohydrolase F lowered the capacity of TGEV virions to induce IFN alpha. Thus, these findings strongly suggest that glycosylation of the viral proteins, and more precisely the presence of complex-type oligosaccharides, is an important requirement for a completely efficient interaction with PBMC leading to the production of IFN-alpha.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amidohydrolases,
http://linkedlifedata.com/resource/pubmed/chemical/Concanavalin A,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon Type I,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide-N4-(N-acetyl-beta-glucosamin...,
http://linkedlifedata.com/resource/pubmed/chemical/Tunicamycin,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0300-9475
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
435-40
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1850168-Amidohydrolases,
pubmed-meshheading:1850168-Animals,
pubmed-meshheading:1850168-Cells, Cultured,
pubmed-meshheading:1850168-Concanavalin A,
pubmed-meshheading:1850168-Dose-Response Relationship, Drug,
pubmed-meshheading:1850168-Dose-Response Relationship, Immunologic,
pubmed-meshheading:1850168-Glycosylation,
pubmed-meshheading:1850168-Interferon Type I,
pubmed-meshheading:1850168-Leukocytes, Mononuclear,
pubmed-meshheading:1850168-Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase,
pubmed-meshheading:1850168-Swine,
pubmed-meshheading:1850168-Transmissible gastroenteritis virus,
pubmed-meshheading:1850168-Tunicamycin,
pubmed-meshheading:1850168-Viral Proteins
|
pubmed:year |
1991
|
pubmed:articleTitle |
Glycosylation is required for coronavirus TGEV to induce an efficient production of IFN alpha by blood mononuclear cells.
|
pubmed:affiliation |
Laboratoire de Virologie et d'Immunologie Moléculaires, I.N.R.A., Centre de Recherches de Jouy-en-Josas, France.
|
pubmed:publicationType |
Journal Article,
In Vitro
|